ESC
🔍 Search peptides, guides, and research...
↑↓ navigate   open   esc close

Thymagen: Thymus Bioregulator for Immune Support

compounds

Thymagen is a dipeptide bioregulator designed to support thymus function and immune regulation. It’s part of the Khavinson peptide bioregulator family from Russian research.

What Is Thymagen?

  • Type: Synthetic dipeptide bioregulator
  • Target Tissue: Thymus gland, immune system
  • Origin: St. Petersburg Institute of Bioregulation and Gerontology
  • Sequence: Glu-Trp (Glutamic acid - Tryptophan)

Why the Thymus Matters

The thymus is where T-cells mature — critical for adaptive immunity. It:

  • Begins shrinking after puberty (thymic involution)
  • Significantly atrophied by age 50-60
  • Reduced function = weaker immune response in aging

Thymagen aims to support remaining thymus function and T-cell production.

Mechanism of Action

  • Binds to DNA regulatory sequences in thymic cells
  • May upregulate genes involved in T-cell development
  • Proposed to slow age-related thymic decline
  • Immunomodulatory rather than immunostimulant (regulates, doesn’t just boost)

Research

Russian studies show:

  • Improved T-cell markers in aging subjects
  • Enhanced vaccine response in elderly populations
  • Reduced infection frequency in some clinical observations

Limitations: Most research from Russian sources, limited Western replication.

Dosing Protocol

Oral Form

ParameterRecommendation
Dose10 mg (typically 1 capsule)
Frequency1-2x daily
TimingBefore meals
Duration10-30 days
Cycling1-2 courses per year

Injectable Form

  • 10-20 mcg subcutaneous
  • Once daily for 10-20 days

Who Uses Thymagen?

  • Older adults — age-related immune decline
  • Frequent illness — recurrent infections, slow recovery
  • Post-illness recovery — supporting immune rebound
  • Preventive use — maintaining immune function with aging

What to Expect

Effects are subtle and cumulative:

  • May reduce frequency of minor infections over time
  • Potentially faster recovery from illness
  • No immediate “boost” feeling — this isn’t a stimulant
  • Benefits assessed over months, not days

Side Effects

Well-tolerated in available data:

  • No significant adverse effects reported
  • No immunosuppression concerns at standard doses
  • Avoid in autoimmune conditions (theoretical — limited data)

Comparison to Thymalin

Both target thymus, but:

  • Thymagen: Synthetic dipeptide, oral or injectable
  • Thymalin: Thymus extract, older compound
  • Thymagen is more targeted; Thymalin contains multiple factors

Stacking

Common combinations:

  • Epithalon — telomere support + immune support
  • Sigumir — joints + immune (general anti-aging stack)
  • Vitamin D — synergistic immune support

The Honest Take

Thymagen represents an interesting approach to age-related immune decline. The thymus atrophies in everyone — interventions targeting this are worth exploring. However, Western clinical data is sparse. Consider it experimental, potentially useful for immune support in aging, but not a replacement for standard health practices.


For immune-related peptides, see also Thymosin Alpha-1. For general healing peptides, see BPC-157 Guide.